Skip to main content
Journal ArticleOPEN ACCESS

Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada

Open Forum Infectious Diseases (2021) 8(11)
DOI: 10.1093/ofid/ofab492
2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Initiation of human immunodeficiency virus preexposure prophylaxis (PrEP) medications will also treat hepatitis B infection (HBV). The prevalence of chronic HBV was 0.86% (n = 41/4760) among enrollees in a provincial PrEP program in British Columbia, Canada. Overall, 46.3% lacked follow-up HBV DNA monitoring, underscoring the need for HBV-related education for PrEP prescribers.

Author supplied keywords

Cited by Powered by Scopus

Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B

The Lancet HIV
8Citations
N/AReaders
Get full text

Sociodemographic and clinical follow-up profile of transgender people accessing pre-exposure prophylaxis for the risk of HIV transmission in São Paulo, Brazil (2018-2021)

Epidemiologia e Servicos de Saude
0Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Thompson, K. A., Blank, G., Toy, J., Moore, D. M., Lachowsky, N., Bacani, N., … Hull, M. W. (2021). Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada. Open Forum Infectious Diseases, 8(11). https://doi.org/10.1093/ofid/ofab492

Readers over time

‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Nursing and Health Professions 2

40%

Chemistry 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0